U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.1129C>A (p.Arg377Ser) AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Dec 17, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003102308.3

Allele description [Variation Report for NM_000162.5(GCK):c.1129C>A (p.Arg377Ser)]

NM_000162.5(GCK):c.1129C>A (p.Arg377Ser)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.1129C>A (p.Arg377Ser)
Other names:
NM_000162.5(GCK):c.1129C>A; p.Arg377Ser
HGVS:
  • NC_000007.14:g.44145621G>T
  • NG_008847.2:g.57550C>A
  • NM_000162.5:c.1129C>AMANE SELECT
  • NM_001354800.1:c.1129C>A
  • NM_001354801.1:c.118C>A
  • NM_001354802.1:c.-12C>A
  • NM_001354803.2:c.163C>A
  • NM_033507.3:c.1132C>A
  • NM_033508.3:c.1126C>A
  • NP_000153.1:p.Arg377Ser
  • NP_001341729.1:p.Arg377Ser
  • NP_001341730.1:p.Arg40Ser
  • NP_001341732.1:p.Arg55Ser
  • NP_277042.1:p.Arg378Ser
  • NP_277043.1:p.Arg376Ser
  • LRG_1074t1:c.1129C>A
  • LRG_1074t2:c.1132C>A
  • LRG_1074:g.57550C>A
  • LRG_1074p1:p.Arg377Ser
  • LRG_1074p2:p.Arg378Ser
  • NC_000007.13:g.44185220G>T
  • NM_000162.3:c.1129C>A
Protein change:
R376S
Molecular consequence:
  • NM_001354802.1:c.-12C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_000162.5:c.1129C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354800.1:c.1129C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354801.1:c.118C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354803.2:c.163C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033507.3:c.1132C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033508.3:c.1126C>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003439928Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Dec 17, 2021)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.

Osbak KK, Colclough K, Saint-Martin C, Beer NL, Bellanné-Chantelot C, Ellard S, Gloyn AL.

Hum Mutat. 2009 Nov;30(11):1512-26. doi: 10.1002/humu.21110. Review.

PubMed [citation]
PMID:
19790256

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV003439928.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This missense change has been observed in individual(s) with maturity-onset diabetes of the young (PMID: 19790256). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 377 of the GCK protein (p.Arg377Ser).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024